EUR 3.14
(0.0%)
Year | Net Income | Net Income Growth |
---|---|---|
2023 | 1.5 Million EUR | -96.18% |
2022 | 39.24 Million EUR | 993.58% |
2021 | -4.39 Million EUR | 68.85% |
2020 | -14.09 Million EUR | 0.7% |
2019 | -14.19 Million EUR | -57.95% |
2018 | -8.98 Million EUR | 4.84% |
2017 | -9.44 Million EUR | 21.62% |
2016 | -12.05 Million EUR | -5603.2% |
2015 | 219 Thousand EUR | 101.24% |
2014 | -17.64 Million EUR | -520.03% |
2013 | -2.84 Million EUR | -32.43% |
2012 | -2.14 Million EUR | -6.54% |
2011 | -2.01 Million EUR | 10.99% |
2010 | -2.26 Million EUR | 0.0% |
Year | Net Income | Net Income Growth |
---|---|---|
2023 Q4 | 1.67 Million EUR | 0.0% |
2023 Q2 | -177 Thousand EUR | 0.0% |
2022 Q2 | -3.24 Million EUR | 0.0% |
2022 FY | 39.24 Million EUR | 993.58% |
2022 Q4 | -2.8 Million EUR | 0.0% |
2021 Q2 | -2.83 Million EUR | 0.0% |
2021 FY | -4.39 Million EUR | 68.85% |
2021 Q4 | -1.55 Million EUR | 0.0% |
2020 Q2 | -4.98 Million EUR | 0.0% |
2020 Q4 | -9.11 Million EUR | 0.0% |
2020 FY | -14.09 Million EUR | 0.7% |
2019 FY | -14.19 Million EUR | -57.95% |
2019 Q2 | 5.3 Million EUR | 0.0% |
2019 Q4 | -19.49 Million EUR | 0.0% |
2018 Q4 | -1.76 Million EUR | 0.0% |
2018 FY | -8.98 Million EUR | 4.84% |
2018 Q2 | -7.22 Million EUR | 0.0% |
2017 Q4 | -975 Thousand EUR | 0.0% |
2017 Q2 | -8.47 Million EUR | 0.0% |
2017 FY | -9.44 Million EUR | 21.62% |
2016 Q2 | -5.67 Million EUR | 0.0% |
2016 FY | -12.05 Million EUR | -5603.2% |
2016 Q4 | -6.37 Million EUR | 0.0% |
2015 Q4 | 1.32 Million EUR | 0.0% |
2015 FY | 219 Thousand EUR | 101.24% |
2015 Q2 | -1.1 Million EUR | 0.0% |
2014 FY | -17.64 Million EUR | -520.03% |
2014 Q4 | -7.41 Million EUR | 0.0% |
2014 Q2 | -10.22 Million EUR | 0.0% |
2013 Q4 | -444 Thousand EUR | 0.0% |
2013 Q2 | -2.4 Million EUR | 0.0% |
2013 FY | -2.84 Million EUR | -32.43% |
2012 Q1 | -504.25 Thousand EUR | 0.0% |
2012 Q3 | -537.25 Thousand EUR | 0.0% |
2012 Q4 | -537.25 Thousand EUR | 0.0% |
2012 FY | -2.14 Million EUR | -6.54% |
2012 Q2 | -537.25 Thousand EUR | -6.54% |
2011 Q2 | -504.25 Thousand EUR | 10.99% |
2011 Q1 | -566.5 Thousand EUR | 0.0% |
2011 Q4 | -504.25 Thousand EUR | 0.0% |
2011 FY | -2.01 Million EUR | 10.99% |
2011 Q3 | -504.25 Thousand EUR | 0.0% |
2010 Q4 | -566.5 Thousand EUR | 0.0% |
2010 FY | -2.26 Million EUR | 0.0% |
2010 Q2 | -566.5 Thousand EUR | 0.0% |
2010 Q3 | -566.5 Thousand EUR | 0.0% |
Name | Net Income | Net Income Difference |
---|---|---|
Crossject Société Anonyme | -8.63 Million EUR | 117.365% |
Safe Orthopaedics SA | -6.96 Million EUR | 121.536% |
Spineway SA | -6.51 Million EUR | 123.041% |
Sartorius Stedim Biotech S.A. | 309.7 Million EUR | 99.516% |
EssilorLuxottica Société anonyme | 2.28 Billion EUR | 99.934% |
bonyf N.V. | -1.04 Million EUR | 243.581% |